MX2014008020A - Compuestos de fenil carbamato para uso en la prevencion o tratamiento de epilepsia. - Google Patents

Compuestos de fenil carbamato para uso en la prevencion o tratamiento de epilepsia.

Info

Publication number
MX2014008020A
MX2014008020A MX2014008020A MX2014008020A MX2014008020A MX 2014008020 A MX2014008020 A MX 2014008020A MX 2014008020 A MX2014008020 A MX 2014008020A MX 2014008020 A MX2014008020 A MX 2014008020A MX 2014008020 A MX2014008020 A MX 2014008020A
Authority
MX
Mexico
Prior art keywords
preventing
phenyl carbamate
treating
epilesy
carbamate compounds
Prior art date
Application number
MX2014008020A
Other languages
English (en)
Other versions
MX353024B (es
Inventor
Yong Moon Choi
Original Assignee
Bio Pharm Solutions Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Pharm Solutions Co Ltd filed Critical Bio Pharm Solutions Co Ltd
Publication of MX2014008020A publication Critical patent/MX2014008020A/es
Publication of MX353024B publication Critical patent/MX353024B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/02—Carbamic acids; Salts of carbamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/12—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/24—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/26—Polyhydroxylic alcohols containing only six-membered aromatic rings as cyclic part
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/36—Polyhydroxylic alcohols containing six-membered aromatic rings and other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Un compuesto fenil carbamato, una composición farmacéutica para la prevención y/o tratamiento de la epilepsia comprometiendo al compuesto fenil carbamato como un ingrediente activo, y un uso del compuesto fenil carbamato para la prevención y/o tratamiento de la epilepsia, son previstos.
MX2014008020A 2011-12-27 2012-12-26 Compuestos de fenil carbamato para uso en la prevencion o tratamiento de epilepsia. MX353024B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161580409P 2011-12-27 2011-12-27
PCT/KR2012/011474 WO2013100570A1 (en) 2011-12-27 2012-12-26 Phenyl carbamate compounds for use in preventing or treating epilesy

Publications (2)

Publication Number Publication Date
MX2014008020A true MX2014008020A (es) 2014-12-08
MX353024B MX353024B (es) 2017-12-18

Family

ID=48655156

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2014008021A MX338554B (es) 2011-12-27 2012-12-26 Compuestos de fenil carbamato para usarse en aliviar o tratar el dolor.
MX2014008020A MX353024B (es) 2011-12-27 2012-12-26 Compuestos de fenil carbamato para uso en la prevencion o tratamiento de epilepsia.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2014008021A MX338554B (es) 2011-12-27 2012-12-26 Compuestos de fenil carbamato para usarse en aliviar o tratar el dolor.

Country Status (13)

Country Link
US (6) US20130203846A1 (es)
EP (6) EP2797881B1 (es)
JP (8) JP2015504055A (es)
KR (6) KR101795563B1 (es)
CN (6) CN104136413B (es)
AU (2) AU2012360365B2 (es)
BR (2) BR112014015482A8 (es)
CA (2) CA2858977C (es)
ES (3) ES2710902T3 (es)
IN (2) IN2014MN01432A (es)
MX (2) MX338554B (es)
RU (2) RU2632659C2 (es)
WO (6) WO2013100569A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9018253B2 (en) 2010-07-02 2015-04-28 Bio-Pharm Solutions Co., Ltd. Phenylcarbamate compound and muscle relaxant containing the same
EP2797881B1 (en) * 2011-12-27 2018-11-14 Bio-Pharm Solutions Co., Ltd. Phenyl alkyl carbamate derivative compound and pharmaceutical composition containing the same
KR101717872B1 (ko) * 2013-03-12 2017-03-17 (주)바이오팜솔루션즈 소아 간질 및 간질-관련 증후군의 예방 또는 치료용 페닐카바메이트 화합물
EP2970109A4 (en) * 2013-03-12 2017-01-18 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compound and a composition for neuroprotection comprising the same
KR101792999B1 (ko) * 2013-12-12 2017-11-02 (주)바이오팜솔루션즈 간질 예방 또는 치료용 설파메이트 유도체 화합물
ES2704928T3 (es) * 2013-12-12 2019-03-20 Bio Pharm Solutions Co Ltd Compuestos derivados de sulfamato para su uso en el tratamiento o alivio del dolor
JP6807941B2 (ja) * 2016-02-29 2021-01-06 バイオ−ファーム ソリューションズ カンパニー リミテッド スルファメート誘導体化合物、その製造方法および用途
EP3697908A1 (en) 2017-10-16 2020-08-26 Voyager Therapeutics, Inc. Treatment of amyotrophic lateral sclerosis (als)
KR102005019B1 (ko) 2018-04-04 2019-07-31 한국과학기술연구원 뇌졸중의 예방 및 치료용 조성물
WO2020010042A1 (en) 2018-07-02 2020-01-09 Voyager Therapeutics, Inc. Treatment of amyotrophic lateral sclerosis and disorders associated with the spinal cord
US20210361318A1 (en) 2018-07-02 2021-11-25 Voyager Therapeutics, Inc. Cannula system and use thereof
KR102427769B1 (ko) 2020-08-07 2022-08-02 한국과학기술연구원 다발성 경화증 예방 또는 치료용 조성물
KR102531540B1 (ko) 2020-09-18 2023-05-16 한국과학기술연구원 류마티스 관절염 예방 또는 치료용 조성물
KR102614653B1 (ko) 2021-06-09 2023-12-20 한국과학기술연구원 신규한 헤테로사이클릴-페닐-메틸아민 유도체, 이의 제조방법 및 이의 다발성 경화증 예방, 개선, 또는 치료 용도
KR102399807B1 (ko) * 2021-08-05 2022-05-20 (주)바이오팜솔루션즈 페닐카바메이트 결정형 및 이의 제조 방법
EP4382509A1 (en) 2021-08-05 2024-06-12 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate crystalline form and method for preparing same

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2884444A (en) 1956-01-13 1959-04-28 Carter Prod Inc 2-phenyl-1,3 propane diol dicarbamate
US2937119A (en) 1959-06-11 1960-05-17 Carter Prod Inc Nu-monosubstituted-2, 2-dialkyl-1, 3-propanediol dicarbamates
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3313699A (en) * 1962-06-26 1967-04-11 Armour Pharma Compositions for and method of treating the central nervous system
US3265727A (en) 1962-06-26 1966-08-09 Armour Pharma Phenyl alkyl-1, 2 dicarbamates
US3313696A (en) 1962-06-26 1967-04-11 Armour Pharmacentical Company Carbamate sedative compositions and method of use
US3313700A (en) * 1962-07-18 1967-04-11 Armour Pharmacentical Company Method of treating the central nervous system with substituted phenethyl carbamates and compositions therefor
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
FR5671M (es) * 1965-04-23 1968-01-02
US3600427A (en) 1967-05-08 1971-08-17 Anthony J Verbiscar Phenyl carbamate latentiated phenethylamines
JPS61271992A (ja) * 1985-05-28 1986-12-02 Central Glass Co Ltd 光学活性ジオ−ルの製造方法
WO1994027941A1 (en) * 1993-05-25 1994-12-08 Avondale Chemical Company Process for preparing felbamate and intermediates thereto
US20010034365A1 (en) * 1996-01-16 2001-10-25 Choi Yong Moon Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
US6242468B1 (en) * 1997-02-27 2001-06-05 Jia-He Li Carbamate and urea compositions and neurotrophic uses
DE60033050T2 (de) * 1999-11-29 2007-11-15 Mitsubishi Rayon Co., Ltd. Acetalsulfonat-derivate, verfahren zu ihrer herstellung und verfahren zur herstellung eines styroloxid-derivats
GB0004297D0 (en) * 2000-02-23 2000-04-12 Ucb Sa 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses
HUP0303236A3 (en) 2001-02-27 2012-07-30 Ortho Mcneil Pharm Inc Carbamate compounds for use in the treatment of pain
CN1235579C (zh) * 2001-02-27 2006-01-11 奥索-麦克尼尔药品公司 用于预防或治疗神经变性疾病的氨基甲酸酯化合物
MXPA03008999A (es) 2001-04-02 2004-02-12 Astrazeneca Ab Composicion farmaceutica solida que comprende 4-ciano -trifluor-3 -(4-fluorfenilsulfonil) -2-hidroxi-2 -metilpropino -m-toluidida y pvp.
ATE373475T1 (de) 2001-06-25 2007-10-15 Sk Corp Carbamate von 2-heterozyklischen 1,2-ethandiolen
CA2454049A1 (en) 2001-07-16 2003-01-30 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain
EP2248799B1 (en) * 2001-12-21 2015-05-20 SK Biopharmaceuticals Co., LTD Process for preparing 2-(substituted phenyl)-2-hydroxy-ethyl carbamates
FR2836915B1 (fr) * 2002-03-11 2008-01-11 Aventis Pharma Sa Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
WO2003101917A2 (en) 2002-05-31 2003-12-11 Sun Pharmaceutical Industries Limited A process for the preparation of phenylcarbamates
US6897217B2 (en) * 2003-04-23 2005-05-24 Schering Corporation 2-Alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists
WO2005044093A2 (en) 2003-11-05 2005-05-19 Unimed Pharmaceuticals, Inc. Delta-9- the treatment of multiple sclerosis
TW200538118A (en) * 2004-04-21 2005-12-01 Schering Corp Pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists
NZ552336A (en) * 2004-06-08 2010-12-24 Families Of Spinal Muscular Atrophy 2,4-Diaminoquinazolines for spinal muscular atrophy
US20060194873A1 (en) * 2004-09-16 2006-08-31 Choi Yong M Methods of treating epileptogenesis and epilepsy
CN101076327A (zh) * 2004-10-15 2007-11-21 詹森药业有限公司 用于治疗神经变性疾病的氨基甲酸酯化合物
US7442438B2 (en) 2005-05-04 2008-10-28 3M Innovative Properties Company Wet and dry stick adhesive, articles, and methods
TW200800954A (en) 2006-03-16 2008-01-01 Astrazeneca Ab Novel crystal modifications
US7737141B2 (en) * 2006-07-28 2010-06-15 Eisai R&D Management Co., Ltd. Prodrug of cinnamide compound
CN101472913A (zh) * 2006-07-28 2009-07-01 卫材R&D管理有限公司 肉桂酰胺化合物的前药
EA200970355A1 (ru) * 2006-10-06 2009-12-30 Янссен Фармацевтика Нв Новый кристалл (s)-(+)-2-(2-хлорфенил)-2-гидроксиэтилкарбамата
EA200970378A1 (ru) * 2006-10-13 2009-10-30 Янссен Фармацевтика, Н. В. Композиции фенилалкилкарбамата
US20080103198A1 (en) 2006-10-27 2008-05-01 Haas Magali Methods for treatment of cochlear and vestibular disorders
CN101568362A (zh) 2006-10-30 2009-10-28 詹森药业有限公司 治疗抑郁症的方法
PE20081775A1 (es) * 2006-12-20 2008-12-18 Bristol Myers Squibb Co Compuestos macrociclicos como inhibidores del factor viia
CA2683398A1 (en) * 2007-04-10 2008-10-16 Sgx Pharmaceuticals, Inc. Fused ring heterocycle kinase modulators
WO2009022345A1 (en) 2007-08-14 2009-02-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Phenyl carbamates for the treatment of multiple sclerosis
US20090105498A1 (en) * 2007-10-18 2009-04-23 Porstmann Frank Improved process for preparing 2-(substituted phenyol)-2-hydroxy-ethyl-carbamates
WO2010022300A1 (en) 2008-08-21 2010-02-25 Forest Laboratories Holdings Limited Methods for treating neuropathic pain
JP2011219387A (ja) * 2010-04-06 2011-11-04 Kaneka Corp イオン液体の製造方法
CA2803825C (en) * 2010-07-02 2015-12-29 Bio-Pharm Solutions Co., Ltd. Phenylcarbamate compound and muscle relaxant containing the same
US9018253B2 (en) 2010-07-02 2015-04-28 Bio-Pharm Solutions Co., Ltd. Phenylcarbamate compound and muscle relaxant containing the same
CA2815460C (en) * 2011-01-13 2017-04-18 Bio-Pharm Solutions Co., Ltd. Process for preparation of phenyl carbamate derivatives
CN103635472B (zh) * 2011-02-28 2018-01-12 阵列生物制药公司 丝氨酸/苏氨酸激酶抑制剂
EP2797881B1 (en) * 2011-12-27 2018-11-14 Bio-Pharm Solutions Co., Ltd. Phenyl alkyl carbamate derivative compound and pharmaceutical composition containing the same

Also Published As

Publication number Publication date
BR112014015482A2 (pt) 2017-06-13
US9162975B2 (en) 2015-10-20
JP2015508398A (ja) 2015-03-19
ES2710902T3 (es) 2019-04-29
EP2797880A4 (en) 2015-10-07
CN104136415B (zh) 2016-09-07
JP2015504053A (ja) 2015-02-05
EP2797877A1 (en) 2014-11-05
US20130165509A1 (en) 2013-06-27
AU2012360362B2 (en) 2017-08-31
IN2014MN01436A (es) 2015-07-03
CN104136413B (zh) 2016-10-26
CN104136415A (zh) 2014-11-05
KR20150023217A (ko) 2015-03-05
MX2014008021A (es) 2014-08-01
KR101880584B1 (ko) 2018-07-20
RU2014124029A (ru) 2016-02-20
CN104870421A (zh) 2015-08-26
AU2012360362A1 (en) 2014-08-07
CA2859129C (en) 2020-07-14
CA2858977A1 (en) 2013-07-04
KR20140108245A (ko) 2014-09-05
ES2624989T3 (es) 2017-07-18
ES2716832T3 (es) 2019-06-17
JP2015503550A (ja) 2015-02-02
JP6298766B2 (ja) 2018-03-20
EP2797877A4 (en) 2015-10-07
EP2797879A4 (en) 2015-10-07
WO2013100568A1 (en) 2013-07-04
KR20140113919A (ko) 2014-09-25
WO2013100566A8 (en) 2014-02-20
EP2797880A1 (en) 2014-11-05
JP6155280B2 (ja) 2017-06-28
US9034848B2 (en) 2015-05-19
JP2015504055A (ja) 2015-02-05
US20130165408A1 (en) 2013-06-27
WO2013100571A1 (en) 2013-07-04
WO2013100571A9 (en) 2014-09-18
WO2013100569A1 (en) 2013-07-04
EP2797876A4 (en) 2015-10-07
EP2797878B1 (en) 2017-08-16
BR112014015568A2 (pt) 2017-06-13
BR112014015482A8 (pt) 2017-07-04
CN104136414A (zh) 2014-11-05
KR20140108226A (ko) 2014-09-05
WO2013100567A1 (en) 2013-07-04
WO2013100567A8 (en) 2014-02-20
RU2014124028A (ru) 2016-02-20
AU2012360365B2 (en) 2017-08-31
EP2797878A4 (en) 2015-10-07
US20130165409A1 (en) 2013-06-27
EP2797880B1 (en) 2017-03-01
MX338554B (es) 2016-04-20
CN104136416A (zh) 2014-11-05
EP2797881A4 (en) 2016-01-13
EP2797881A1 (en) 2014-11-05
RU2632659C2 (ru) 2017-10-09
KR101795562B1 (ko) 2017-11-08
CA2859129A1 (en) 2013-07-04
BR112014015568A8 (pt) 2017-07-04
JP6089045B2 (ja) 2017-03-01
US9029589B2 (en) 2015-05-12
KR20140113914A (ko) 2014-09-25
BR112014015568B1 (pt) 2022-03-29
JP2015504054A (ja) 2015-02-05
US20130184338A1 (en) 2013-07-18
CN104169253B (zh) 2016-11-09
JP2015506934A (ja) 2015-03-05
US20130165410A1 (en) 2013-06-27
WO2013100566A1 (en) 2013-07-04
CN104169253A (zh) 2014-11-26
EP2797881B1 (en) 2018-11-14
JP6298765B2 (ja) 2018-03-20
MX353024B (es) 2017-12-18
CN104136413A (zh) 2014-11-05
KR20140113918A (ko) 2014-09-25
EP2797876A1 (en) 2014-11-05
EP2797878A1 (en) 2014-11-05
US9624164B2 (en) 2017-04-18
IN2014MN01432A (es) 2015-07-03
EP2797879A1 (en) 2014-11-05
CN104136416B (zh) 2016-11-09
JP2018108996A (ja) 2018-07-12
JP2017193577A (ja) 2017-10-26
KR101795563B1 (ko) 2017-11-08
EP2797879B1 (en) 2018-12-26
KR101862203B1 (ko) 2018-05-29
WO2013100570A1 (en) 2013-07-04
CA2858977C (en) 2020-06-23
US20130203846A1 (en) 2013-08-08
AU2012360365A1 (en) 2014-08-07

Similar Documents

Publication Publication Date Title
MX2014008020A (es) Compuestos de fenil carbamato para uso en la prevencion o tratamiento de epilepsia.
EP2883875A4 (en) DERIVED FROM N2, N4-BIS (4- (PIPERAZIN-1-YL) PHENYL) PIRIMIDINE-2,4-DIAMINE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND COMPOSITION CONTAINING THE SAME AS ACTIVE SUBSTANCE FOR PREVENTING OR TREATING CANCER
MY163083A (en) Solid forms of a pharmaceutically active substance
TN2013000255A1 (en) Aminoindanes amides having a high fungicidal activity and their phytosanitary compositions
IL233154A (en) Compounds, pharmaceuticals containing them and their uses
MX2013012542A (es) Compuestos de amida y aplicacion farmaceutica para el mismo.
ZA201406866B (en) Herbicidal composition comprising uracil compound as active ingredient
EA201390885A1 (ru) Азаиндолы в качестве противовирусных агентов против респираторного синцитиального вируса
EP2742019A4 (en) N1-CYCLIC-AMIN-N5-SUBSTITUTED BIGUANIDE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION THEREWITH
MX2014014832A (es) Pirrolopirimidona y pirrolopiridona, inhibidores de tanquirasa.
IT1404931B1 (it) Composizioni oftalmiche per la somministrazione di principi attivi liposolubili .
WO2013055687A3 (en) R(+)-n-formyl-propargyl-aminoindan
EP2970111A4 (en) Phenyl carbamate compound and a composition for preventing or treating a nerve gas-induced disease comprising the same
PH12015501429A1 (en) Herbicidal composition
MX364934B (es) Agente para prevenir y/o tratar dolor neuropático periférico causado por fármaco contra el cáncer.
PH12015501400A1 (en) Herbicidal composition comprising a cornexistin
WO2012118308A3 (ko) 피라졸 유도체를 포함하는 심혈관 질환 예방 및 치료용 조성물.
WO2012002773A3 (en) Phenylcarbamate compound and muscle relaxant containing the same
MX2014015345A (es) Inhibidores piranopiridona de tanquirasa.
IN2014DN10669A (es)
EP2871187A4 (en) NOVEL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS ACTIVE INGREDIENT
EP2784061A4 (en) ACYLHYDRACO AND OXADIAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND THEIR USE THEREOF
EP3037091A4 (en) Composition containing monoacetyldiacylglycerol compound as active ingredient for preventing or treating asthma
EP2910246A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF CANCER WITH ENOBLOCK AS AN ACTIVE SUBSTANCE
EP2476420A4 (en) PHARMACEUTICAL COMPOSITION WITH ANTIMICROBIAL AND FAST HEALING EFFECT FOR EXTERNAL ADMINISTRATION AND MANUFACTURING METHOD THEREFOR

Legal Events

Date Code Title Description
FG Grant or registration